Clinical Trial Update: Cognitive Remediation for HIV-associated Neurocognitive Dysfunction [NA]

View source ↗

Summary

The clinical trial NCT02671526 evaluating cognitive remediation for HIV-associated neurocognitive disorder has completed. Sponsored by Posit Science Corporation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Neurocognitive Disorder

Snippet

Sponsor: Posit Science Corporation | Conditions: HIV-associated Neurocognitive Dysfunction | NA | Status: COMPLETED